Cargando…
C‐PLAN index as a prognostic factor for patients with previously untreated advanced non‐small cell lung cancer who received combination immunotherapy: A multicenter retrospective study
BACKGROUND: Combination immunotherapy (immune checkpoint inhibitors and cytotoxic anticancer agents) is widely used as first‐line treatment for advanced non‐small cell lung cancer (NSCLC). However, the therapeutic effect of combination immunotherapy has not been fully investigated. C‐reactive protei...
Autores principales: | Sonehara, Kei, Ozawa, Ryota, Hama, Mineyuki, Nozawa, Shuhei, Agatsuma, Toshihiko, Nishie, Kenichi, Kato, Akane, Matsuo, Akemi, Araki, Taisuke, Komatsu, Masamichi, Tateishi, Kazunari, Hanaoka, Masayuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968595/ https://www.ncbi.nlm.nih.gov/pubmed/36635979 http://dx.doi.org/10.1111/1759-7714.14798 |
Ejemplares similares
-
Rechallenge of afatinib for EGFR-mutated non-small cell lung cancer previously treated with osimertinib: a multicenter phase II trial protocol (REAL study)
por: Araki, Taisuke, et al.
Publicado: (2023) -
Predictive value of post‐treatment C‐reactive protein‐to‐albumin ratio in locally advanced non–small cell lung cancer patients receiving durvalumab after chemoradiotherapy
por: Araki, Taisuke, et al.
Publicado: (2022) -
Pulmonary Spindle Cell Carcinoma Presenting Anaplastic Lymphoma Kinase Rearrangement
por: Sonehara, Kei, et al.
Publicado: (2023) -
Pembrolizumab-Induced Adrenal Insufficiency in Patients with Untreated Advanced Non-Small Cell Lung Cancer: A Case Series
por: Sonehara, Kei, et al.
Publicado: (2021) -
Prognostic value of the geriatric nutritional risk index among patients with previously treated advanced non‐small cell lung cancer who subsequently underwent immunotherapy
por: Sonehara, Kei, et al.
Publicado: (2021)